Software Firm GitLab Prices US$800 Million IPO

Software company GitLab Inc. (Nasdaq: GTLB) started trading on the Nasdaq Global Select Market Thursday under the ticker symbol “GTLB”. The firm aims to raise US$800.8 million in its debut on the big board.

The offering consisted of 10.4 million Class A common shares at US$77.00 per share. The company is selling 8.42 million shares out of the offering while the remaining 1.98 million shares will be sold by the existing stockholder affiliated with GitLab CEO and chair Sytse Sijbrandij. GitLab said it will not receive any proceeds from the latter.

Goldman Sachs & Co., J.P. Morgan, and BofA Securities are acting as the lead bookrunners for the said offering. The underwriters were given a 30-day over-allotment option to purchase up to an additional 1.04 million shares at the same IPO price.

Silver47 Exploration Inc. — sponsored Sponsored · Silver47 Exploration Inc.

The offering is expected to close on October 18, 2021, subject to customary closing conditions.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

A $2.2B Gold Project Is Outgrowing Its Plan | Michael Henrichsen – Gold X2 Mining

Pay for the Copper, Get the Gold Free | Rob McEwen – McEwen Inc

This Gold Discovery Was Already Huge. Now It’s Becoming a Monster. | Goliath Resources

Recommended

Rackla Metals Adds Two Northern Development Veterans to Board as Lentung Advances

Northmin Hits 12.85% Copper and 933 g/t Silver in Highest Grade Tynagh Assays Yet

Related News

Tech SPAC Denali Capital Acquisition Prices US$75 Million IPO

Special purpose acquisition company Denali Capital Acquisition Corp. (Nasdaq: DECAU) started trading publicly on the...

Friday, April 8, 2022, 02:19:00 PM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Fintech Firm Blend Labs Seeks US$360 Million In IPO

Blend Labs Inc. announced this morning the launch of its initial public offering on the...

Tuesday, July 6, 2021, 11:20:00 AM

SpaceX Cuts IPO Valuation Target to $1.8 Trillion After Investor Feedback

SpaceX lowered its initial public offering valuation target to at least $1.8 trillion on Thursday,...

Friday, May 29, 2026, 02:11:55 AM

Biotech Firm Blue Water Vaccines Prices US$20 Million IPO

Biopharmaceutical company Blue Water Vaccines, Inc. (Nasdaq: BWV) began trading on the Nasdaq Capital Market...

Monday, February 21, 2022, 04:33:00 PM